Regeneron Pharmaceuticals Inc.

Veloci-BiFull-Length Bispecific Antibodies

SHARE

Veloci-Bi allows for the generation of full-length bispecific antibodies similar to native antibodies that are amenable to production by standard antibody manufacturing techniques and likely to have favorable antibody-like pharmacokinetic properties.

Most popular related searches